We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It'll be sold in 4 weeks. £3 a share dividend.
They might be just setting up office etc having no intention of further development of stemprinter. This may result in a higher price once listed as a bonafide co.
JohnLaw Surely this is not a subsidiary company since the RNS specifies it will be an independent company. Therefore the only time the cash can be rolled up with the company is prior to separation. I also read it would be £1m. Perhaps enough to set up an office, small lab but hardly enough to get very far with progressing the technology through to trials.
Is that not correct?
Spinnaker
Spinnaker
Mrninjazx6 was my mother's name!
Thank you geronimo, I knew I read it somewhere.
MrNinjazx6,
IPO stated in RNS dated 16 Sept. ( towards the bottom )
vbw
Agree plus any additional developmental costs would be passed on to the buyer negating the need for any additional fundraising. OncotypeDX was a fully developed system when it was sold. As it stands Stem is believed to be circa 40% better. Any sale would need to account for additional development costs plus a discount for risk. We all know what OncotypeDX sold for and I've got a figure in mind that I would consider acceptable if asked to vote on any offer to buy Stem
@raaydar, that would be the simplest solution me thinks, sell it and cash dividend for us all. And I guess it would be easier to sell as a separate company than trying to sell it as a piece if an existing business. Im no expert but that to me would involve a lot of hassle,red tape, and other such legalities.
#fingers crossed emoji
Personally dont think it will be listed. Reckon it's just being packaged up for a sale post demerger and the bod can focus their attentions on the TILS pipeline. Then again wtfdik
Johnlaw and Johnhenry 2 of my now dead old man's drinking buddies back in Belfast.
Yes of course they can hand over cash to their subsidiary. The bookkeeping is Dr Investment in Subsidiary, Cr Bank. When they dividend it to shareholders the entry is Dr P&L account, Cr Investment in Subsidiary. My fees are £2,500, thank you very much.
@house, I was under the impression (rightly or wrongly) that it was going to be IPO'd, I dont recall where I read it, perhaps from another poster on here. Could you get one of your kids to pop on and have a crack at explaining it maybe ;)
@johnhenry, yeah that was my thinking. There eill be more than 190 million shares in issue.
Household you think TILS can just hand over cash to Accustem, Jesus LOLLOLLOL
Incorrect Household, The prospectus states that Accustem will demerge with $1Million.
If Accustem wish to raise funds they will IPO which is the route they are going down imho
Quite simple they will raise money by issuing new shares if they IPO.
If they are not raising cash then they wont IPO they will just list on the main market.
Don't know why I'm answering as I'm not even smarter than my kids.
No need to IPO as TILS will hand over enough cash from their monster pile for the new accustem company to keep the lights on until it is sold for a couple of billion.
Very smart move to back heel the fully developed stemprinter on to the market as a separate sales vehicle whilst taking their other multibillion value products over the finishing line.
Time to sit on hands
GLA
So the situation with accustem is 1 free share for each tils share, 190 million ish give or take. If the majority of the shares are accounted for being held by pi's ii's and BOD, how are they supposed to IPO it when it lists? Is there going to be more than 190 million shares in issue?
Genuinely confused.